Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Joshi

Showing results (431-440 of 455) with videos related to

Pageof 46
Sort By:
South Asian Journal of Cancer|December 22, 2025
Patterns of Failure in Head and Neck Carcinoma of Unknown Primary: Insights from a Tobacco-Associated Cancer CohortSarbani Ghosh Laskar, Jifmi Jose Manjali, Ashwini Budrukkar, et al.
Metabolites|June 27, 2023
Dietary Inflammatory and Insulinemic Potentials, Plasma Metabolome and Risk of Colorectal CancerDong Hoon Lee, Qi Jin, Ni Shi, et al.
Immunology and Cell Biology|September 28, 2021
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patientsPrashant R Tembhare, Harshini Sriram, Gaurav Chatterjee, et al.
Eclinicalmedicine|May 31, 2019
Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung CancerVijay Patil, Vanita Noronha, Amit Joshi, et al.
International Journal of Clinical Practice|June 10, 2022
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of MumbaiArusha Shetty, Gaurav Chatterjee, Sweta Rajpal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority TrialVanita Noronha, Amit Joshi, Vijay Maruti Patil, et al.
BMJ Open Gastroenterology|December 26, 2019
Combined effect of modifiable and non-modifiable risk factors for colorectal cancer risk in a pooled analysis of 11 population-based studiesXiaoliang Wang, Kelli O'Connell, Jihyoun Jeon, et al.
Cancer Medicine|November 17, 2021
Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in IndiaSumeet P Mirgh, Anant Gokarn, Akhil Rajendra, et al.
Cancer Medicine|October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatmentAnant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
International Journal of Cancer|December 10, 2021
Genetic variants associated with circulating C-reactive protein levels and colorectal cancer survival: Sex-specific and lifestyle factors specific associationsYuhan Huang, Xinwei Hua, Julia D Labadie, et al.
Pageof 46

Showing results (431-440 of 455) with videos related to

Sort By:
Pageof 46
South Asian Journal of Cancer|December 22, 2025
Patterns of Failure in Head and Neck Carcinoma of Unknown Primary: Insights from a Tobacco-Associated Cancer CohortSarbani Ghosh Laskar, Jifmi Jose Manjali, Ashwini Budrukkar, et al.
Metabolites|June 27, 2023
Dietary Inflammatory and Insulinemic Potentials, Plasma Metabolome and Risk of Colorectal CancerDong Hoon Lee, Qi Jin, Ni Shi, et al.
Immunology and Cell Biology|September 28, 2021
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patientsPrashant R Tembhare, Harshini Sriram, Gaurav Chatterjee, et al.
Eclinicalmedicine|May 31, 2019
Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung CancerVijay Patil, Vanita Noronha, Amit Joshi, et al.
International Journal of Clinical Practice|June 10, 2022
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of MumbaiArusha Shetty, Gaurav Chatterjee, Sweta Rajpal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority TrialVanita Noronha, Amit Joshi, Vijay Maruti Patil, et al.
BMJ Open Gastroenterology|December 26, 2019
Combined effect of modifiable and non-modifiable risk factors for colorectal cancer risk in a pooled analysis of 11 population-based studiesXiaoliang Wang, Kelli O'Connell, Jihyoun Jeon, et al.
Cancer Medicine|November 17, 2021
Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in IndiaSumeet P Mirgh, Anant Gokarn, Akhil Rajendra, et al.
Cancer Medicine|October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatmentAnant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
International Journal of Cancer|December 10, 2021
Genetic variants associated with circulating C-reactive protein levels and colorectal cancer survival: Sex-specific and lifestyle factors specific associationsYuhan Huang, Xinwei Hua, Julia D Labadie, et al.
Pageof 46